financetom
Business
financetom
/
Business
/
Nordstrom Reports Fiscal Q1 Adjusted Loss, Revenue Rises; 2024 Outlook Reaffirmed -- Shares Fall After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nordstrom Reports Fiscal Q1 Adjusted Loss, Revenue Rises; 2024 Outlook Reaffirmed -- Shares Fall After Hours
May 30, 2024 2:23 PM

05:12 PM EDT, 05/30/2024 (MT Newswires) -- Nordstrom ( JWN ) reported a fiscal Q1 adjusted net loss late Thursday of $0.24 per diluted share, compared with earnings of $0.07 per share a year earlier.

Analysts polled by Capital IQ expected a loss of $0.07.

Revenue for the quarter ended May 4 rose to $3.34 billion from $3.18 billion a year earlier.

Analysts surveyed by Capital IQ expected $3.2 billion.

For fiscal 2024, the company said it continues to expect EPS of $1.65 to $2.05.

The consensus is for $1.79.

Nordstrom ( JWN ) also reaffirmed its full-year revenue outlook range indicating a 2% decline to a 1% increase.

The company's shares were down more than 6% in after-hours activity.

Price: 19.63, Change: -1.40, Percent Change: -6.66

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem
BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem
Oct 29, 2025
Oct 29 (Reuters) - NLS Pharmaceutics AG ( NLSP ): * NLS PHARMACEUTICS LTD. ANNOUNCES 1-FOR-10 REVERSE SHARE SPLIT AND NAME CHANGE IN CONNECTION WITH PROPOSED MERGER WITH KADIMASTEM * NLS PHARMACEUTICS ( NLSP ) - REVERSE SPLIT EFFECTIVE IN SWITZERLAND ON OCTOBER 30, 2025 * NLS PHARMACEUTICS ( NLSP ) - COMMON SHARES TO TRADE ON NASDAQ AS NCEL...
Market Chatter: Thermo Fisher Nearing $10 Billion Takeover of Clario
Market Chatter: Thermo Fisher Nearing $10 Billion Takeover of Clario
Oct 29, 2025
06:06 AM EDT, 10/29/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) is close to acquiring drug trial software maker Clario in an all-cash deal that could value the healthcare technology group at about $10 billion, the Financial Times reported Tuesday, citing people familiar with the matter. A deal could be announced as early as Wednesday, two sources told...
Form 8.3 - Spectris PLC
Form 8.3 - Spectris PLC
Oct 29, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Amazon's AWS to Invest Over $5 Billion in South Korea
Amazon's AWS to Invest Over $5 Billion in South Korea
Oct 29, 2025
06:06 AM EDT, 10/29/2025 (MT Newswires) -- Amazon.com's ( AMZN ) cloud computing arm, Amazon Web Services, will invest more than $5 billion to build artificial intelligence data centers in South Korea's Incheon and Gyeonggi regions by 2031, South Korea's presidential office said on Wednesday. The new investment follows AWS's earlier commitment in Ulsan and marks the largest greenfield investment...
Copyright 2023-2026 - www.financetom.com All Rights Reserved